''Gene Solutions presented real-world data on K-TRACK, a novel hybrid circulating tumor DNA (ctDNA) testing approach. This integrative method, combining tumor-informed and tumor-agnostic approach, addresses a critical gap in precision oncology: the challenge of obtaining high-quality tissue specimens in diverse clinical settings.''